Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04274907 |
Title | A Safety Study of Oral Venetoclax in Combination With Intravenous Pembrolizumab in Adult Participants With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) With High Programmed Cell Death Ligand-1 (PD-L1) Expression |
Recruitment | Terminated |
Gender | both |
Phase | Phase I |
Variant Requirements | Yes |
Sponsors | AbbVie |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |